Back
Praxis Precision Medicines Vs. Protagonist Therapeutics Industry Stock Comparison
Buy
73
PRAX
Praxis Precision Medicines
Last Price:
77.05
Seasonality Move:
80.14%
Sell
32
PTGX
Protagonist Therapeutics
Last Price:
41.02
Seasonality Move:
12.96%
Buy
73
Praxis Precision Medicines (PRAX)
is a Buy
Is Praxis Precision Medicines a Buy, Sell or Hold?
- The current Praxis Precision Medicines [PRAX] share price is $81.72. The Score for PRAX is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- PRAX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $42.67. The Score for PTGX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRAX Stock Price Chart
What is Praxis Precision Medicines's stock price today?
-
The Praxis Precision Medicines share price today is $81.72
The current trend is moderately bullish and PRAX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $42.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
PRAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.26 | Buy |
| Relative Strength Index (14 RSI): | 68.4 | Buy |
| Chaikin Money Flow: | -262093 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.03 - 77.59) | Buy |
| Bollinger Bands (100): | (48.26 - 68.6) | Buy |
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 35.81 | Sell |
| Chaikin Money Flow: | -366275 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.81 - 47.77) | Sell |
| Bollinger Bands (100): | (37.08 - 46.34) | Buy |
PRAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.19 | Buy |
| 20-day SMA: | 73.79 | Buy |
| 50-day SMA: | 66.01 | Buy |
| 200-day SMA: | 53.38 | Buy |
| 8-day EMA: | 78.4 | Buy |
| 20-day EMA: | 73.91 | Buy |
| 50-day EMA: | 67.36 | Buy |
| 200-day EMA: | 53.37 | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.8 | Sell |
| 20-day SMA: | 46.52 | Sell |
| 50-day SMA: | 45.56 | Sell |
| 200-day SMA: | 35.25 | Buy |
| 8-day EMA: | 45.25 | Sell |
| 20-day EMA: | 45.9 | Sell |
| 50-day EMA: | 44.83 | Sell |
| 200-day EMA: | 36.55 | Buy |
Praxis Precision Medicines Earnings Growth & PRAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.19 per share, and a decrease next year of $1.62 per share.
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.
Praxis Precision Medicines Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protagonist Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||